Quantro Therapeutics receives non-dilutive research grant from Austrian Research Promotion Agency to advance its AI-driven drug discovery platform.
Round Type
Grant
ViennaBiotechnologyHealth CareArtificial IntelligenceTherapeuticsInvestors
Description
Quantro Therapeutics GmbH, a Vienna-based transcriptomic drug discovery platform provider, received a 12-month non-dilutive research grant from the Austrian Research Promotion Agency (FFG). The grant will support development of ASCEND, the company's AI-driven medicinal chemistry platform for drug discovery. The funding will accelerate the company's pipeline and establish workflows for optimizing small molecule modulators and degraders targeting transcription factors.
Who to call at Quantro Therapeutics, and when
A new round usually means Quantro Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Quantro Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Quantro Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Quantro Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Quantro Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Quantro Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.